← Eichor
Study identifier: NCT07559591 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

High Flow Tracheal Oxygen for Weaning of Tracheostomized Patients

Condition: Tracheostomized Patients · Mechanical Ventilation Weaning · High Flow Oxygen Therapy  ·  Sponsor: King Faisal Specialist Hospital & Research Center

PhaseNA
Planned participants88
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In this pilot randomized controlled trial (RCT), the investigators aim to explore the feasibility of conducting a powered RCT that examines the efficacy and safety of high flow tracheal oxygen (HFTO) in weaning critically ill tracheostomy patients from mechanical ventilation. Objective of the study 1. To assess the feasibility of conducting a larger RCT as primary objective. 2. To explore the effect of using HFTO in mechanically ventilated tracheostomized critically ill patients on ventilator-free days (VFD) compared to standard of care method using tracheal mask (TM) as secondary objective.

This description comes directly from the study's public registry record.

Talk to the study team

Zainab Al Duhailib, MBBS, MSc, EDIC  ·  00966112162919  ·  zainajd@gmail.com

Kafa Abuhdeeb  ·  00966112162919  ·  kabuhdeeb@kfshrc.edu.sa

Always discuss trial participation with your own doctor first.

Locations (1)

King Faisal Specialist Hospital and Research CentreRiyadh, Saudi ArabiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07559591